Current Opinion in Neurology

Papers
(The H4-Index of Current Opinion in Neurology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation90
Update on management of cerebral venous thrombosis85
Management of neuropsychiatric symptoms in dementia53
Assessing treatment response in multiple sclerosis52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis52
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment49
Editorial introductions49
Historical development and contemporary use of neuromodulation in human spinal cord injury45
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population42
Neurosyphilis in 2025: Erratum41
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies39
Central nervous system adverse events of immune checkpoint inhibitors37
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond35
The role of the gut microbiome in Alzheimer's disease pathophysiology30
Gene therapies for CMT neuropathies: from the bench to the clinic30
Hereditary motor neuropathies30
The 2021 WHO classification of central nervous system tumors: what neurologists need to know29
Neurology education in the era of artificial intelligence29
Editorial introductions28
Editorial: Epilepsy advances in 202327
Multiple sclerosis in China: the current state of diagnosis and management27
Updates in neuro-otology27
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial26
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention25
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise25
0.11149096488953